Medical Writer

Nov 30, 2021

The company

Source was founded in 2016 by Directors Juliet Mumby-Croft and David Trueman. We are an independent HEOR consultancy specialising in value communication, health economics, systematic review, and health technology assessment. At Source, we have a supportive and friendly team who are focused on delivering high-quality evidence-based solutions for their clients.

The role

Due to company growth, we are looking to recruit a Medical Writer to join our in-house medical writing team. The role will be based in either Oxford or central London.

We are open to applicants looking for full time or part time (0.8 FTE) working hours.

Duties and responsibilities

  • Provide a medical writing resource to the other technical specialists
  • Planning and writing of market access documents and journal articles
  • Timely delivery of writing deliverables
  • Bespoke research on healthcare interventions and therapeutic areas
  • Analysing clinical studies
  • Proofreading and editing of written material
  • Telephone, email and in-person liaison with co-authors and clients

Requirements

  • At least 18 months’ writing experience in an agency environment
  • A PhD in a relevant scientific subject
  • Excellent communication (written and verbal) and organisational skills
  • Attention to detail
  • Good writing and proofreading skills
  • A proactive approach
  • Ability to understand clinical data and to grasp new therapeutic areas quickly
  • Skilled in Microsoft Word, and proficient at Microsoft PowerPoint and Microsoft Excel

Why work with us?

We are a small company that offers a friendly and informal working environment. We offer fantastic opportunities to develop your career with us. You will receive full support, mentoring and guidance with opportunity for career development.

The package

Competitive salary and benefits package.

How to apply

Please email your CV to Deb Burford, Head of Medical Writing at dburford@source-he.com by 24th January 2022.

 

 

Other opportunities

Medical Writer

The company Source was founded in 2016 by Directors Juliet Mumby-Croft and David Trueman. We are an independent HEOR consultancy specialising in value communication, health economics, systematic review, and health technology assessment. At ...

Oxford or LondonView details

Associate Medical Writer

The company Source was founded in 2016 by Directors Juliet Mumby-Croft and David Trueman. We are an independent HEOR consultancy specialising in value communication, health economics, systematic review, and health technology assessment. At ...

The role is either based in Oxford or Central LondonView details

Systematic Review Analyst

Job Description We are looking for a systematic review analyst to provide support to the systematic review team. We are looking for an enthusiastic and motivated individual who is proactive, shows initiative, and has experience in contributing ...

OxfordView details

What we think

NICE RWE framework 

NICE RWE framework 

Previously, we discussed the use of real-world evidence (RWE) in the reimbursement assessment of medical devices. In this latest blog, we present an overview of the RWE framework created by the National Institute for Health and Care Excellence ... Read more

The 100,000 genomes project: paving the way for faster diagnosis and treatment of rare diseases

The 100,000 genomes project: paving the way for faster diagnosis and treatment of rare diseases

What are rare diseases?  In the  European Union, a rare disease is defined as a disorder affecting ≤5 in 10,000 persons  (1). Using this definition, the global population prevalence of rare diseases is estimated to be between 3.5–‍5.9% ... Read more

Use of RWE in the reimbursement assessment of medical devices

Use of RWE in the reimbursement assessment of medical devices

Hierarchy of evidence  Different study designs are often ranked in a hierarchy of evidence based on their validity and robustness. Randomised controlled trials (RCTs) are typically considered the gold standard source of evidence, ... Read more

The growing number of small interfering RNA-based therapies approved for reimbursement in the UK

The growing number of small interfering RNA-based therapies approved for reimbursement in the UK

The RNA interference pathway  Ribonucleic acid (RNA) is an important macromolecule in cells, involved in turning genetic information encoded by genes (made up of deoxyribonucleic acid ), into proteins needed by the cell. During the processes of ... Read more